RESPIRATORY DIAGNOSTICS: PREPAREDNESS, STEWARDSHIP, AND PERSONALIZED PATIENT CARE

Respiratory Diagnostics: Preparedness, Stewardship, and Personalized Care

Respiratory infections represent both a persistent and significant health burden, necessitating accurate and timely diagnostic capabilities for effective patient management, public health interventions, and outbreak control. As respiratory diagnostics continue with a rapid and exciting pace of change, medical laboratories are positioned at the forefront of transforming patient care through faster, more precise, and data-driven results. These advances include multiplex testing platforms, artificial intelligence, and rapid sequencing workflows that enable rapid identification of respiratory pathogens. These advances are empowering clinicians with clearer answers and more targeted treatment decisions.
Some articles featured in the e-book, “Respiratory Diagnostics: Preparedness, Stewardship, and Personalized Care,” include the following:

Leveraging the flexible future of respiratory diagnostics

The dynamic nature of the annual respiratory burden must be met with options that offer flexibility. Many laboratories have turned to multiplex testing platforms for the diagnosis of respiratory infections. Defined as a syndromic approach to diagnosis, these tests are designed to provide simultaneous results for multiple pathogens that cause similar symptoms, all from a single patient sample.

Beyond the bench: How artificial intelligence is redefining respiratory pathogen diagnostics in the clinical laboratory
Artificial intelligence (AI) now emerges as the next frontier in the evolution of respiratory pathogen testing. 

It offers groundbreaking computational abilities to enhance diagnostic speed, improve accuracy, and dramatically reduce turnaround times.

This article describes the different subsets of AI and their purposes in respiratory pathogens identification.

Rapid sequencing workflows deliver comprehensive respiratory pathogens results, faster

The use of a rapid, long-read sequencing platform can help clinical laboratory teams achieve their respiratory pathogen testing goals. This approach can deliver whole genome or metagenomic sequencing data in less than a day, enabling same-day reporting of results to guide clinical interventions. A sequencing-based approach also allows for an unbiased view, enabling discovery of co-infections and unexpected or unculturable pathogens.  

Sponsored by: Applied BioCode, Diasorin, ELITechGroup MDx, Qiagen, QuidelOrtho, ZeptoMetrix